Our analysis yielded significant findings, demonstrating a notably higher abundance of tumor-reactive B cells, CD4, CD8 T cells, and dendritic cells in responder patients compared to their non-responder counterparts (Fig. S2A–C). The gene discussed is CD4; the disease is neoplasm.